Under the proposed agreement with Regeneron, the Tarrytown, New York, drugmaker will acquire 23andMe's assets, including its personal genome service and total health and research services.

Marymount University has reached a significant milestone in its Strategic Plan trajectory as it has been designated a Research University for 2025 by the American Council on Education (ACE) and ...

Twenty-two custom-designed stained-glass windows were the inspiration for the first renovation to the Sacred Heart of Mary Chapel in its 62-year history at the heart of the Marymount University ...

The Tarrytown, New York-based pharmaceutical company pledged to remain compliant with 23andMe’s consumer-privacy rules and vowed to work with a court-appointed ombudsman who will investigate the ...

NEW YORK — “Obviously, we want to take the next step. We want to be better than we were last year.” That was the gauntlet Jalen Brunson threw down at the Knicks’ media day session in ...

Regeneron, the Tarrytown, New York-based pharmaceutical company, agreed to purchase 23andMe for $256 million, following the saliva test kit company's bankruptcy in March. The company plans to ...

Now serving as the bench boss of the New York Rangers, Sullivan hasn’t forgotten, nor will he ever forget, his time in Pittsburgh and the success he had. In a classy gesture from Sullivan ...

Through the deal, Tarrytown, New York-based Regeneron aims to bolster its capabilities in genomics-driven drug discovery by integrating 23andMe's trove of more than 15 million customer DNA ...